Amanote Research
Register
Sign In
Therapeutic and Prophylactic Effects of a Protective Monoclonal Antibody (MAb-001) Against the Pathogenic Haemoflagellate Cryptobia Salmositic
Diseases of Aquatic Organisms
- Germany
doi 10.3354/dao028211
Full Text
Open PDF
Abstract
Available in
full text
Categories
Evolution
Ecology
Systematics
Aquatic Science
Behavior
Date
January 1, 1997
Authors
S Feng
PTK Woo
Publisher
Inter-Research Science Center
Related search
Possible Future Monoclonal Antibody (mAb)-Based Therapy Against Arbovirus Infections
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Epitope Characterization of the Protective Monoclonal Antibody VN04-2 Shows Broadly Neutralizing Activity Against Highly Pathogenic H5N1
Virology Journal
Virology
Infectious Diseases
The Therapeutic Monoclonal Antibody Market
mAbs
Allergy
Immunology
Therapeutic Effects of Monoclonal Antibody Against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection
Journal of Immunology
Allergy
Immunology
Understanding the Interaction Effects Between a Monoclonal Antibody and HBsAg by Molecular Dynamics Aiming the Affinity mAb Improvement
Production and Characterization of a Monoclonal Antibody Against Enrofloxacin
Journal of Microbiology and Biotechnology
Applied Microbiology
Biotechnology
Medicine
Cross-Protective Potential of a Novel Monoclonal Antibody Directed Against Antigenic Site B of the Hemagglutinin of Influenza a Viruses
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics
Protection Against Candidiasis by an Immunoglobulin G3 (IgG3) Monoclonal Antibody Specific for the Same Mannotriose as an IgM Protective Antibody
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Substrate-Based Inhibitors Exhibiting Excellent Protective and Therapeutic Effects Against Botulinum Neurotoxin a Intoxication
Scientific Reports
Multidisciplinary
